Does On-Site Adequacy Assessment by Cytotechnologists Improve Results of EUS guided FNA of Solid Pancreaticobiliary Lesions?

  • Manu K Nayar HPB Unit, Freeman Hospital, Royal Victoria Infirmary. Newcastle upon Tyne, United Kingdom
  • Suvadip Chatterjee HPB Unit, Freeman Hospital, Royal Victoria Infirmary. Newcastle upon Tyne, United Kingdom
  • Viney Wadehra Department of Cellular Pathology, Royal Victoria Infirmary. Newcastle upon Tyne, United Kingdom
  • Joanne Cunningham Department of Cellular Pathology, Royal Victoria Infirmary. Newcastle upon Tyne, United Kingdom
  • John Leeds HPB Unit, Freeman Hospital, Royal Victoria Infirmary. Newcastle upon Tyne, United Kingdom
  • Kofi Oppong HPB Unit, Freeman Hospital, Royal Victoria Infirmary. Newcastle upon Tyne, United Kingdom
Keywords: Biopsy, Fine-Needle, Cytological Techniques, Endoscopic Ultrasound-Guided Fine Needle Aspiration, Endosonography, Pancreatic Neoplasms, Pancreatitis, Chronic


Context Rapid onsite adequacy assessment is stated to improve the diagnostic performance of EUS-FNA. Objectives The aim of this study was to establish if the introduction of adequacy assessment performed by a biomedical scientist (cytotechnologist) to an established EUS service improved the diagnostic accuracy of EUS guided FNA of solid pancreaticobiliary lesions. Design and Patients This retrospective study includes all patients with solid pancreaticobiliary lesions who underwent EUS-FNA from April 2009 to September 2010. An in room cytotechnologist was present for 2 out of the 4 weekly EUS lists and therefore there were  two groups identified: Group 1, cytotechnologist absent; and Group 2, cytotechnologist present. Results There were 82 patients in Group 1 and 97 patients in Group 2. There was no statistically significant difference in the number of passes (4.1 vs. 4.3), the inadequate aspirate rate (7.3% vs. 5.1%) or the mean size of the lesions (34.7 vs. 32.6 mm) between the groups. The accuracy, sensitivity, specificity, positive predictive value and negative predictive value in Group 1 were 89%, 88%, 100%, 100% and 50% respectively. The results in Group 2 were 91%, 90%, 100%, 100% and 69% respectively. There was no statistically significant difference between the two groups. Conclusions In this study the adequacy assessment performed by a cytotechnologist did not improve the diagnostic accuracy of EUS-FNA. In an established EUS-FNA service with low inadequate aspirate rates, onsite adequacy assessment may not improve results of the test.

Image: Royal Victoria Infirmary. Newcastle upon Tyne, United Kingdom.


Download data is not yet available.

Author Biography

Manu K Nayar, HPB Unit, Freeman Hospital, Royal Victoria Infirmary. Newcastle upon Tyne, United Kingdom


Varadarajulu S, Eloubeidi MA. The role of endoscopic ultrasonography in the evaluation of pancreaticobiliary cancer. Surg Clin North Am. 2010;90:251-63.

Mansfield SD, Scott J, Oppong K, Richardson DL, Sen G, Jaques BC et al. Comparison of multislice computed tomography and endoscopic ultrasonography with operative and histological findings in suspected pancreatic and periampullary malignancy. Br J Surg 2006.;95:1512-20.

Kala Z, Válek V, Hlavsa J, Hana K, Hana K, Vánová A. The role of CT and endoscopic ultrasound in pre-operative staging of pancreatic cancer. Eur J Radiol. 2007;62:166-9.

Dewitt J, Devereaux BM, Lehman GA, Sherman S, Imperiale TF. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol. 2006;4:717-25

Eloubeidi MA, Chen VK, Eltoum IA, Jhala D, Chhieng DC, Jhala N et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Am J Gastroenterol. 2003;98:2663- 2670.

Harewood GC, Wiersema MJ. Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. Am J Gastroenterol 2002;97:1386-91.

Turner BG, Cizginer S, Agarwal D, Yang J, Pitman MB, Brugge WR Diagnosis of pancreatic neoplasia with EUS and FNA: a report of accuracy. Gastrointest Endosc. 2010;71:91-8.

Robins DB, Katz RL, Evans DB, Atkinson EN, Green L. Fine needle aspiration of the pancreas. In quest of accuracy. Acta Cytol. 1995;39:1-10

Erickson RA, Sayage-Rabie L, Beissner RS. Factors predicting the number of EUS-guided fine-needle passes for diagnosis of pancreatic malignancies. Gastrointest Endosc 2000;51:184-90.

Layfield LJ, Bentz JS, Gopez EV. Immediate on-site interpretation of fine-needle aspiration smears: a cost and compensation analysis. Cancer 2001;93:319-22.

Hall TL, Layfield LJ, Philippe A, Rosenthal DL. Sources of diagnostic error in fine needle aspiration of the thyroid. Cancer. 1989;63:718-25.

Austin JH, Cohen MB Value of having a cytopathologist present during percutaneuous fine-needle aspiration biopsy of lung: report of 55 cancer patients and metaanalysis of the literature. AJR Am J Roentgenol. 1993;160:175-7.

Miller DA, Carrasco CH, Katz RL, Cramer FM, Wallace S, Charnsangavej .Fine needle aspiration biopsy: the role of immediate cytologic assessment. AJR Am J Roentgenol. 1986;147:155-8.

Palombini L, Fulciniti F, Vetrani A, De Rosa G, Di Benedetto G, Zeppa P et al. Fine-needle aspiration biopsies of breast masses. A critical analysis of 1956 cases in 8 years (1976-1984). Cancer. 1988;61:2273-7.

Exact confidence limits for p. Geigy Scientific Tables, 7th Ed.Ciba-Geigy Ltd., Basle: Switzerland, p85-98.

Volmar KE, Vollmer RT, Jowell PS, Nelson RC, Xie HB. Pancreatic FNA in 1000 cases: a comparison of imaging modalities. Gastrointest Endosc 2005;61:854-61.

Puri R, Vilmann P, Săftoiu A, Skov BG, Linnemann D, Hassan H et al. Randomized controlled trial of endoscopic ultrasound-guided fine-needle sampling with or without suction for better cytological diagnosis Scandinavian Journal of Gastroenterology 2009,;44: 499-504:

Krishna NB, Mehra M, Reddy AV, Agarwal B. EUS/EUS-FNA for suspected pancreatic cancer: influence of chronic pancreatitis and clinical presentation with or without obstructive jaundice on performance characteristics. Gastrointest Endosc. 2009;70:70-9.

Alsibai KD, Denis B, Bottlaender J, Kleinclaus I, Straub P, Fabre M. Impact of cytopathologist expert on diagnosis and treatment of pancreatic lesions in current clinical practice. A series of 106 endoscopic ultrasound-guided fine needle aspirations. Cytopathology. 2006;17:18-26.

Jhala NC, Jhala DN, Chhieng DC, Eloubeidi MA, Eltoum IA. Endoscopic ultrasound-guided fine-needle aspiration. A cytopathologist's perspective. Am J Clin Pathol. 2003;120:351-67.

.Williams DB, Sahai AV, Aabakken L, Penman ID, van Velse A, Webb J et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut 1999;44:720-6.

Wilson JL, Kalade A, Prasad S, Cade R, Thomson B, Banting S et al. Diagnosis of solid pancreatic masses by endoscopic ultrasound-guided fine-needle aspiration. Intern Med J 2009;39:32-7

Erickson RA. EUS-guided FNA. Gastrointest Endosc 2004;60:267-79.

LeBlanc JK, Ciaccia D, Al-Assi MT, McGrath K, Imperiale T, Tao LC et al. Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis. Gastrointest Endosc 2004;59:475-81

Klapman JB, Logrono R, Dye CE, Waxman I. Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol. 2003;98:1289-94.

Iglesias-Garcia J, Dominguez-Munoz JE, Abdulkader I, Larino-Noia J, Eugenyeva E, Lozano-Leon A et al. Influence of On-Site Cytopathology Evaluation on the Diagnostic Accuracy of Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) of Solid Pancreatic Masses. Am J Gastroenterol. 11;106:401-6

Hwang CY, Lee SS, Song TJ, Moon SH, Lee D, Park do H et al. Endoscopic ultrasound guided fine needle aspiration biopsy in diagnosis of pancreatic and peripancreatic lesions: a single center experience in Korea. Gut Liver. 2009;3:116-21

Cherian PT, Mohan P, Douiri A, Taniere P, Hejmadi RK, Mahon BS.Role of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis of solid pancreatic and peripancreatic lesions: is onsite cytopathology necessary? HPB (Oxford). 2010 Aug;12(6):389-95.

Itoi T, Tsuchiya T, Itokawa F, Sofuni A, Kurihara T, Tsuji S et al. Histological diagnosis by EUS-guided fine-needle aspiration biopsy in pancreatic solid masses without on-site cytopathologist: a single-center experience. Dig Endosc. 2011;23:34-8.

Hikichi T, Irisawa A, Bhutani MS, Takagi T, Shibukawa G, Yamamoto G et al. Endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses with rapid on-site cytological evaluation by endosonographers without attendance of cytopathologists. J Gastroenterol. 2009;44:322-8.

Alsohaibani F, Girgis S, Sandha GS. Does onsite cytotechnology evaluation improve the accuracy of endoscopic ultrasound-guided fine needle aspiration biopsy? Can J Gastroenterol 2009;23:26–30.

Savoy AD, Raimondo M, Woodward TA, Noh K, Pungpapong S, Jones AD et al. Can endosonographers evaluate on-site cytologic adequacy? A comparison with cytotechnologists.. Gastrointest Endosc. 2007 Jun;65(7):953-7.

Lee JK, Choi ER, Jang TH, Chung YH, Jang KT, Park SM et al. A prospective comparison of liquid-based cytology and traditional smear cytology in pancreatic endoscopic ultrasound-guided fine needle aspiration. Acta Cytol. 2011;55(5):401-7. Epub 2011 Oct 8.

Nicholson S, Sainsbury JR, Wadehra V, Needham GK, Farndon JR. Use of fine needle aspiration cytology with immediate reporting in the diagnosis of breast disease.. Br J Surg. 1988 Sep;75(9):847-50.

Veale D, Gilmartin JJ, Sumerling MD, Wadehra V, Gibson GJ. Prospective evaluation of fine needle aspiration in the diagnosis of lung cancer. Thorax. 1988 Jul;43(7):540-4.

Swinburn CR, Veale D, Peel ET, Wadehra V, Elliott ST, Sumerling MD et al. A prospective randomized comparison of fine needle aspiration biopsy and fibreoptic bronchoscopy in the investigation of peripheral pulmonary opacities.. Respir Med. 1989 Nov;83(6):493-5.

Petrone MC, Arcidiacono PG, Carrara S, Mezzi G, Doglioni C, Testoni PA. Does cytotechnician training influence the accuracy of EUS-guided fine-needle aspiration of pancreatic masses? Dig Liver Dis. 2012 Apr;44(4):311-4.

Nayar M, Joy D, Wadehra V, Oppong KE. Effect of dedicated and supervised training on achieving competence in EUS-FNA of solid pancreatic lesions. Scand J Gastroenterol. 2011; 46:1-7.

Weynand B, Borbath I, Galant C, Piessevaux H, Deprez PH. Optimizing specimen collection and laboratory procedures reduces the non-diagnostic rate for endoscopic ultrasound-guided fine-needle aspiration of solid lesions of the pancreas.Cytopathology 2011;10:1365-2303

Cleveland P, Gill KR, Coe SG, Woodward TA, Raimondo M, Jamil L et al. An evaluation of risk factors for inadequate cytology in EUS-guided FNA of pancreatic tumors and lymph nodes.. Gastrointest Endosc. 2010 Jun;71(7):1194-9

Royal Victoria Infirmary. Newcastle upon Tyne, United Kingdom
How to Cite
NayarM., ChatterjeeS., WadehraV., CunninghamJ., LeedsJ., & OppongK. (2013). Does On-Site Adequacy Assessment by Cytotechnologists Improve Results of EUS guided FNA of Solid Pancreaticobiliary Lesions?. JOP. Journal of the Pancreas, 14(1), 44-49.